Enzyme chat

Enzyme joins Bioscript Group

May 1, 2024

We are very pleased to announce that Enzyme Communications has become part of Bioscript Group – a global scientific communications and market access consulting partner dedicated to supporting pharmaceutical clients at critical points in the product life cycle.

Our vision for the partnership

As part of Bioscript Group, Enzyme Communications will embark on its next stage of growth, supported by a leadership team with the know-how to help the business mature while continuing to put our clients and their science first. We are excited for the opportunities this partnership will bring to our talented team, and in turn, our clients. Client Services Director and Co-founder Neil Kumar noted “as part of the Bioscript Group, Enzyme Communications will access business support services that give us back the time needed to focus on the next stage of growth and continue to put our clients first.”

Importantly, Enzyme Communications and Bioscript Group share a focus on cutting-edge scientific challenges and deep scientific expertise. This focus, paired with an enviable list of existing clients and a
people-first culture made Bioscript Group the right home for the Enzyme Communications team. Science Communication Director and Co-founder Adam Goodband highlighted “ultimately, we are a team of people who get excited about working on cutting-edge science and repackaging that science in ways that are strategically relevant, creative, and new. In Bioscript Group, we recognise those shared passions, while noting that we offer one another complimentary skill sets which will enhance our offerings to existing clients on both sides.”

Gabrielle Silver, CEO of Bioscript Group, said “Enzyme Communications is a very welcome addition to our portfolio as we continue our journey to become leaders in scientific communications for the life sciences sector. The synergies between our two organisations are clear. Enzyme’s distinctive approach to strategic planning and scientific storytelling bolsters the group’s capabilities and will help our clients think even more creatively about how to define their scientific proposition across target audiences.”

To understand more about Enzyme Communications, or this new and exciting partnership, please contact hello@enzymecomms.com

About Bioscript Group

Established in 2005, Bioscript Group is a global scientific communications and market access consulting partner dedicated to supporting pharmaceutical clients at critical points in the product life cycle. With a comprehensive suite of services across medical communications, regulatory writing, and market access consulting, Bioscript Group helps clients navigate across rare and complex disease, oncology, and immunology.

Headquartered in Macclesfield, UK, with a global presence, the company prides itself on its deep therapeutic knowledge and commitment to scientific excellence.


About Enzyme Communications

Founded in 2019, Enzyme Communications has been focused on delivering science communication services to the healthcare and life sciences industries over the last five years. With a foundation in strategic partnership, underpinned by communication skills, and backed-up by wide ranging production capabilities, Enzyme Communications has supported its clients with advisory and advocacy programmes, international events, global clinical trial communications, creative campaigns, product launches, and more… By building on traditional medical communication skills, Enzyme Communications has been able to help its clients go further to break down complex science and tell the stories that matter most.

Give us a call

+44 (0) 20 8058 8389

Drop us an email


Visit us

1-2 Hatfields

Get in touch